Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2010
06/09/2010CN101724075A Remodeling and glycoconjugation of peptides
06/09/2010CN101724074A Humanized chimeric antibody of angiostatin receptor beta subunit, preparation thereof and application thereof
06/09/2010CN101724073A Monoclonal antibody of broad spectrum anti-ras gene expressed protein and preparation method thereof
06/09/2010CN101724072A Sequence and application thereof of anti-tumor monoclonal antibody
06/09/2010CN101724029A Anti-tumor protein and preparation method and application thereof
06/09/2010CN101724028A Parasporal crystal protein with antitumor activity, encoding gene thereof and preparation method of parasporal crystal protein
06/09/2010CN101724025A Anti-tumor toad polypeptide and preparation method and application thereof
06/09/2010CN101724021A Polypeptide conjugates of taxol or docetaxel
06/09/2010CN101724019A Thymopeptide-5 active esters, medicinal composition containing same and application thereof
06/09/2010CN101724018A 2-(2-methacrylamide triglycyl) aminomalonate ester as well as preparation method and application thereof
06/09/2010CN101724011A Preparation method and application of tumor tissue complete antigen
06/09/2010CN101724010A Preparation method and application of tumor tissue complete antigen
06/09/2010CN101724008A Marsdenia tenacissima C21 steroidal glycoside converted product and preparation method and application thereof
06/09/2010CN101724007A Oleanolic acid derivatives and application thereof serving as alpha-glucosidase inhibitor
06/09/2010CN101724003A Ginsenoside Rg1 containing impure notoginsenoside R1
06/09/2010CN101723982A Platinum complex compound with antitumor activity and synthesis method thereof
06/09/2010CN101723956A Crystal transformation process of (3,5-bis-trifluoromethyl)-6-amino-4H-(1,2) dithiol (4,3-b) pyrrole-5-ketone
06/09/2010CN101723952A Anticancer active xanthones and preparation method and use thereof
06/09/2010CN101723951A Oridonin derivative and preparation method thereof
06/09/2010CN101723948A C-6 modified indazolylpyrrolotriazines
06/09/2010CN101723938A Synthesis processes and bioactivities of 3-aromatic (hetero)-6,8-dyhydroxy isoflavonoid compounds
06/09/2010CN101723936A Kinase suppressor and pharmaceutical application thereof
06/09/2010CN101723935A 1,5-diaryl-substituted 2,4-dienone derivative as well as preparation method and application thereof
06/09/2010CN101723932A Nitropyridine ethylenimine compound, medicinal composition, preparation method and application thereof
06/09/2010CN101723909A Triazolone compound as well as preparation method and application thereof
06/09/2010CN101723907A O-dicyano-acenaphtho pyrazine compound and anti-tumor application thereof
06/09/2010CN101723906A Compound, medical composition containing same as well as preparation method and application
06/09/2010CN101723896A Tyrosine derivative histone deacetylases inhibitor and application thereof
06/09/2010CN101723894A N-quinoline amide derivatives and preparation method and application thereof
06/09/2010CN101723890A Aryl thiourea and preparation method and application thereof
06/09/2010CN101723813A Ethoxy diphenyl ethane derivative and preparation method and application thereof
06/09/2010CN101721715A Compound of tumor targeted nonviral gene vector and plasmid DNA and preparation method thereof
06/09/2010CN101721714A Passive targeting antitumor prodrug of solid tumor and preparation method thereof
06/09/2010CN101721710A Cholesteryl-carboxymethyl Curdlan nanometer particle and preparing method
06/09/2010CN101721706A Medicine composition containing matrine class alkaloid, preparation method and pharmaceutical application
06/09/2010CN101721701A Crystallization of antibodies or fragments thereof
06/09/2010CN101721700A Lyophilized preparation of anti-human Her2 antibody
06/09/2010CN101721697A Anti-cancer and anti-infectious disease compositions and methods for using same
06/09/2010CN101721684A Immunowakeup microsystem as well as preparation method and application thereof
06/09/2010CN101721680A Application of variable lymphocyte receptor (VLR) of agnatha in pharmacy
06/09/2010CN101721679A Pharmaceutical compositions for prevention or treatment of lewis y antigen related diseases and kits for detecting lewis y antigen
06/09/2010CN101721644A Traditional Chinese medicine for treating liver cancer
06/09/2010CN101721619A Externally-applied traditional Chinese medicine composition for treating brain stem tumors and preparation method thereof
06/09/2010CN101721610A Medicine for treating tumors
06/09/2010CN101721609A Traditional Chinese medicine sachet for postoperative recovery and preparation method thereof
06/09/2010CN101721545A Anti-tumor Chinese medicinal composition and preparation method thereof
06/09/2010CN101721513A Pharmaceutical composition for preventing and treating cancer and health food containing the same for preventing and treating cancer
06/09/2010CN101721502A Traditional Chinese medicine composition for treating esophagus cancer and preparation method
06/09/2010CN101721461A High dispersion preparation of rabdosia rubescens total terpenoid extract
06/09/2010CN101721452A New process for improving utilization ratio of lithospermum
06/09/2010CN101721446A Method for preparing composite oligosaccharide granules
06/09/2010CN101721442A Method for preparing ginseng soaked by rice vinegar
06/09/2010CN101721435A Ganoderma lucidum spore and nano selenium compound and preparation method thereof
06/09/2010CN101721434A Active ingredients of fomes officinalis, preparation method thereof and use thereof
06/09/2010CN101721417A Entogastric lingering floating slow-release tablet for treating malignant tumor of gastrointestinal tract
06/09/2010CN101721411A Novel use of derivative of phenanthroline
06/09/2010CN101721401A Application of beta hydroxyisovaleryl shikonin in medicament production
06/09/2010CN101721397A Medical application of 6-shogaol for treating cervical cancer, leukemia and breast cancer
06/09/2010CN101721394A Granisetron and/or hydrochloride patch thereof
06/09/2010CN101721372A Gold shell coated hollow mesoporous silicon dioxide spheres, method for preparing same and application thereof in tumor treatment
06/09/2010CN101721370A Goserelin release microsphere preparation, preparation method and detecting method thereof
06/09/2010CN101721364A Aqueous dispersion of camptothecin analogue-phospholipid complex and method for preparing same
06/09/2010CN101721350A Folate-mediated targeted polymeric micelle
06/09/2010CN101390828B Anticancer composition loaded with anti-metabolism medicine and synergist thereof
06/09/2010CN101280316B Therapeutic vaccine for human cervical carcinoma
06/09/2010CN101259116B Externally-applied drug delivery preparations containing bullatacin part medicine exquisite articles
06/09/2010CN101230339B Bombina maxima non-crystalline beta gamma-crystallin and trefoil factor protein compound ,gene as well as preparation and use thereof
06/09/2010CN101215313B Marsdenia tenacissima carbon-21 steroid saponin mixture with antineoplastic effect
06/09/2010CN101172120B Anti-liver cancer gecko Chinese actinidia root compound preparations
06/09/2010CN101167789B Tumor recovering capsule and production method thereof
06/09/2010CN101073599B Total tanshinone and total phenolic acid extract in red-rooted salvia root and its production
06/09/2010CN101010076B Immune function-improving agent
06/08/2010US7732622 Naphthalene derivatives
06/08/2010US7732617 Tocopherol derivatives and uses thereof
06/08/2010US7732601 salt formation in solvent; inoculation
06/08/2010US7732588 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for mediated by angiogenesis, such as solid tumors and vascular deficiencies of cardiac or peripheral tissue
06/08/2010US7732584 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in cancers; provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer
06/08/2010US7732490 Treating non-Hodgkin's lymphoma with suberoylanilide hydroxamic acid (SAHA, vorinostat)
06/08/2010US7732484 Use of selective adenosine A1 receptor allosteric enhancers to manipulate angiogenesis
06/08/2010US7732458 Methods for preparing dehydrocavidine, dehydroapocavidine or their composition, their use and medicinal composition containing them
06/08/2010US7732456 such as 4-benzyloxy-1-{4-[2-(dimethylamino)ethoxy]phenyl}-1H-pyridin-2-one, that as antagonists to melanin concentrating hormone receptors, used for treating cardiovascular, nervous system, metabolic, reproductive system, respiratory system and gatrointestinal disorders
06/08/2010US7732447 such as 4-Pyridin-3-yl-2,5-dihydro-pyridazino[4,5-b]indol-1-one, used as inhibitors of vascular endothelial growth factor receptor (VEGFR) kinase, mixed lineage kinase (MLK) or cyclin-dependent kinase (CDK); treatment of angiogenic disorders and neurodegenerative diseases
06/08/2010US7732445 Pyridazinyl compounds such as 11-(6-imino-3-phenylpyridazin-1(6H)-yl)-N-(2-(1-methylpyrrolidin-2-yl)ethyl)-undecanamide, use for the treatment of tissue barrier dysfunction, tumor metastasis and related disease states
06/08/2010US7732442 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases
06/08/2010US7732439 Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
06/08/2010US7732422 TRPM-2 antisense therapy
06/08/2010US7732412 Methods of treatment using novel LHRH antagonists having improved solubility properties
06/08/2010US7732186 Recombinant methods and materials for producing epothilone and epothilone derivatives
06/08/2010US7732146 Method for screening an agent that modulates activity of macrophage migration inhibitory factor
06/08/2010US7732144 assessing levels of expression of Thymidylate Synthase (TS) and Excision Repair Cross-Complementing (ERCC1) mRNA obtained from fixed or fixed and paraffin-embedded (FPE) tumor cells
06/08/2010US7731961 Methods of increasing muscle mass or muscle strength using antibody inhibitors of GDF-8
06/08/2010US7731951 Viruses for the treatment of cellular proliferative disorders
06/08/2010US7731950 Attack of tumor cells with missing, low or aberrant MHC expression by combining non MHC-restricted T-cells/NK-cells and MHC-restricted cells
06/08/2010US7731945 Immunotherapy for reversing immune suppression
06/08/2010CA2575902C Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide
06/08/2010CA2479642C 4-anilino quinazoline derivatives as antiproliferative agents
06/08/2010CA2439241C Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
06/08/2010CA2388063C Cytotoxic agents comprising taxanes and their therapeutic use
06/08/2010CA2369300C Water-soluble compositions of bioactive lipophilic compounds
06/08/2010CA2368135C Xylo-lna analogues
1 ... 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 ... 2211